Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-α in nude mice bearing pancreatic tumors

Journal of Chinese Integrative Medicine

Volumn 8, Issue 7, 2010, Pages 655-661

  Ouyang, Hua Qiang ^a   Liu, Lu Ming ^a   Chen, Zhen ^a   Luo, Jian Min ^a   Yu, Er Xin ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Compound (TCD); Interleukin 6; Interleukin 8; Mice, nude; Pancreatic adenocarcinoma; Tumor necrosis factor

Indexed keywords

CAPECITABINE; GUM ARABIC; HERBACEOUS AGENT; INTERLEUKIN 6; INTERLEUKIN 8; QINGYI HUAJI; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CANCER INHIBITION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; LOW DRUG DOSE; MOUSE; NONHUMAN; PANCREAS TUMOR; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PHYTOTHERAPY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955452303     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20100709     Document Type: Article

References (16)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
2. Shen YH, Liu LM, Meng ZQ, Chen Z, Lin JH, Zhou ZH, Chen H, Wang K, Yu EX. Survival analysis on 64 cases of advanced pancreatic cancer treated by integrated Western and traditional Chinese medicine mainly with Qingyi Huaji Formula. Zhong Yi Za Zhi. 2009;50(1):39-42. Chinese with abstract in English.
3. Shen YH, Liu LM, Chen Z, Meng ZQ, Song MZ, Yu EX. Study on Chinese medicine combined with chemotherapy for treatment of 32 cases of advanced pancreatic cancer. Zhong Yi Za Zhi. 2006;47(2):115-117. Chinese with abstract in English.
4. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer. 2004;101(12):2727-2736. (Pubitemid 39603180)
5. McIntosh JC, Schoumacher RA, Tiller RE. Pancreatic adenocarcinoma in a patient with cystic fibrosis. Am J Med. 1988;85(4):592.
6. Fujimoto-Ouchi K, Onuma E, Shirane M, Mori K, Tanaka Y. Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models. Cancer Chemother Pharmacol. 2007; 59(6):807-815.
7. Ninomiya I, Terada I, Yoshizumi T, Takino T, Nagai N, Morita A, Fushida S, Nishimura G, Fujimura T, Ohta T, Miwa K. Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum. Int J Cancer. 2004;112(1):135-142.
8. Shen YH, Liu LM, Shen J, Li DL. Impact of QINGYIXIAOJI Formula on proliferation and cell cycle of experimental pancreatic cancer in vivo. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi. 2006;12(2):97-99. Chinese with abstract in English.
9. Liu LM. On pathological mechanism and disease-based treatment of pancreatic cancer in traditional Chinese medicine. J Chin Integr Med. 2008;6(12):1297-1299. Chinese.
10. Fu J, Liu LM, Shen J, Li DL. Effects of Qingyi Huaji decoction plus gemcitabine on expression of MDR and antitumor activity in transplanted-tumors of pancreatic cancer in nude mice. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi. 2007;13(4):289-291. Chinese.
11. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr. Activation of human polymorphonuclear neutrophil functions by interferongamma and tumor necrosis factors. J Immunol. 1985;135(3):2069-2073. (Pubitemid 16240038)
12. Tsimberidou AM, Estey E, Wen S, Pierce S, Kantarjian H, Albitar M, Kurzrock R. The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes. Cancer. 2008;113(7):1605-1613.
13. Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma. Neoplasma. 2009;56(1):56-62.
14. Saif MW, Eloubeidi MA, Russo S, Steg A, Thornton J, Fiveash J, Carpenter M, Blanquicett C, Diasio RB, Johnson MR. Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. J Clin Oncol. 2005;23(34):8679-8687.
15. Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig Dis Sci. 2009;54(3):683-689.
16. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84(4):1045-1049. (Pubitemid 19247571)